Anders Sundin Selected Research

Ga(III)-DOTATOC

11/2021	Receptor depletion and recovery in small-intestinal neuroendocrine tumors and normal tissues after administration of a single intravenous dose of octreotide measured by 68Ga-DOTATOC PET/CT.
1/2020	Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using 68Ga-DOTATOC and 68Ga-DOTATATE.
5/2017	Parametric Net Influx Rate Images of 68Ga-DOTATOC and 68Ga-DOTATATE: Quantitative Accuracy and Improved Image Contrast.
10/2013	Comparative biodistribution and radiation dosimetry of 68Ga-DOTATOC and 68Ga-DOTATATE in patients with neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anders Sundin Research Topics

Disease

44	Neoplasms (Cancer) 11/2021 - 09/2002
29	Neuroendocrine Tumors (Neuroendocrine Tumor) 03/2022 - 09/2002
11	Neoplasm Metastasis (Metastasis) 05/2021 - 12/2003
10	Carcinoid Tumor (Carcinoid) 01/2017 - 09/2002
5	Adrenocortical Adenoma (Disease, Conn's) 05/2022 - 04/2009
5	Disease Progression 01/2021 - 01/2012
5	Colorectal Neoplasms (Colorectal Cancer) 08/2007 - 03/2005
4	Pheochromocytoma 01/2021 - 01/2016
4	Paraganglioma (Paragangliomas) 01/2021 - 05/2007
4	Adrenal Cortex Neoplasms (Adrenocortical Cancer) 01/2016 - 03/2003
3	Adrenal incidentaloma 05/2022 - 02/2009
3	Melanoma (Melanoma, Malignant) 11/2021 - 04/2016
3	Lymphatic Metastasis 05/2021 - 09/2002
3	Neuroendocrine Carcinoma 01/2021 - 01/2012
3	Primitive Neuroectodermal Tumors (PNET) 01/2020 - 04/2015
3	Adenoma (Adenomas) 01/2017 - 04/2006
2	Myelolipoma 11/2021 - 01/2021
2	Hyperaldosteronism (Conn Syndrome) 01/2021 - 01/2016
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 02/2015
2	Pseudarthrosis (Pseudoarthrosis) 03/2017 - 01/2014
2	Hamartoma 01/2017 - 04/2016
2	Cushing Syndrome 10/2008 - 12/2003
1	Hyperplasia 11/2021
1	Cholangiocarcinoma 11/2021
1	Ovarian Neoplasms (Ovarian Cancer) 11/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2021
1	Mastocytosis 02/2021
1	Systemic Mastocytosis 02/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2021
1	Polycythemia Vera 02/2021
1	Adrenal Rest Tumor 01/2021
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2021
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2021
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 12/2019
1	Hemorrhage 05/2018
1	Peritoneal Neoplasms 01/2018
1	Congenital Abnormalities (Deformity) 03/2017
1	Gastro-enteropancreatic neuroendocrine tumor 09/2016

Drug/Important Bio-Agent (IBA)

14	Somatostatin Receptors (Somatostatin Receptor)IBA 11/2021 - 12/2003
11	Peptide Receptors (Peptide Receptor)IBA 11/2021 - 02/2015
10	lutetium Lu 177 dotatateIBA 04/2021 - 02/2015
9	Radioisotopes (Radionuclides)IBA 11/2021 - 02/2015
8	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 11/2021 - 07/2004
7	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2021 - 02/2009
6	metomidateIBA 01/2021 - 03/2003
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2012
5	Hormones (Hormone)IBA 05/2022 - 07/2004
4	Peptides (Polypeptides)IBA 11/2021 - 01/2008
4	Ga(III)-DOTATOCIBA 11/2021 - 10/2013
4	Octreotide (Sandostatin)FDA LinkGeneric 11/2021 - 09/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 01/2004
3	Edotreotide (SMT 487)IBA 05/2021 - 02/2014
3	gallium Ga 68 dotatateIBA 01/2020 - 10/2013
3	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2008 - 09/2002
3	AntigensIBA 08/2007 - 10/2005
2	LipidsIBA 05/2022 - 01/2017
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2021 - 09/2014
2	IodineIBA 12/2019 - 07/2012
2	CatecholaminesIBA 06/2019 - 01/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2016 - 03/2005
2	Streptozocin (Streptozotocin)FDA Link 01/2016 - 06/2012
2	Cisplatin (Platino)FDA LinkGeneric 06/2012 - 01/2004
2	EnzymesIBA 01/2012 - 04/2004
2	Serotonin (5 Hydroxytryptamine)IBA 01/2007 - 09/2002
2	Monoclonal AntibodiesIBA 11/2006 - 07/2006
2	Carbidopa (Lodosyn)FDA LinkGeneric 04/2004 - 09/2002
1	CD40 Ligand (CD40L)IBA 11/2021
1	Interleukin-8 (Interleukin 8)IBA 11/2021
1	Cosyntropin (Cortrosyn)FDA LinkGeneric 01/2021
1	SaltsIBA 01/2021
1	AndrogensIBA 01/2021
1	EstersIBA 01/2021
1	Etomidate FDA LinkGeneric 01/2021
1	GlucocorticoidsIBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	LigandsIBA 01/2020
1	Chromogranin AIBA 01/2020
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 12/2019
1	Ephedrine FDA LinkGeneric 06/2019
1	gallium 68 PSMA-11IBA 01/2019
1	FluoridesIBA 03/2017
1	4-toluenesulfonyl fluoride (TSF)IBA 03/2017
1	Messenger RNA (mRNA)IBA 09/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2016

Therapy/Procedure

27	Therapeutics 03/2022 - 07/2006
4	Radioimmunotherapy 08/2007 - 03/2005
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2007
3	Radiotherapy 01/2020 - 10/2017
2	Precision Medicine 01/2021 - 01/2015
2	Osteotomy 03/2017 - 01/2014
2	Radiofrequency Ablation 08/2012 - 01/2007
2	Premedication 04/2004 - 09/2002
1	Injections 11/2021
1	Transplantation 02/2021
1	Stem Cell Transplantation 02/2021
1	Adrenalectomy 01/2021
1	Blood Transfusion (Blood Transfusions) 05/2018
1	Laparotomy 01/2018